Simultaneous quantitative determination of celecoxib and its two metabolites using liquid chromatography-tandem mass spectrometry in alternating polarity switching mode

Authors
Oh, Hyun-AKim, DonghakLee, Soo HyunJung, Byung Hwa
Issue Date
2015-03-25
Publisher
ELSEVIER SCIENCE BV
Citation
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, v.107, pp.32 - 39
Abstract
A simple and rapid quantitative analytical method for the simultaneous detection of celecoxib and its two main metabolites, hydroxycelecoxib (celecoxib-OH) and celecoxib carboxylic acid (celecoxib-COOH), in rat plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. The plasma sample was prepared through simple protein precipitation, and the reconstitution solution (0.1% formic acid in 50% methanol) was optimized to achieve the best peak shape and recovery. The analytes were separated using an Atlantis T3 column (2.1 mm x 100 mm, 3 mu m), and the mobile phase was composed of 10 mM ammonium formate in either 5% acetonitrile or 95% acetonitrile. The detection of the analytes was performed in alternating polarity switching mode using electrospray ionization. As celecoxib-OH and celecoxib-COOH were slightly unstable following freeze-thaw cycles and long-term storage at -80 degrees C in stability tests, every analysis was carefully conducted with one-freeze thaw cycle and a short storage duration (<1 week). Acceptable accuracy (<15%) and precision (<15%) were obtained in intra- and inter-day validations. The method was successfully applied to the pharmacokinetic study of celecoxib, celecoxib-OH and celecoxib-COOH following the oral administration of celecoxib in rats at a dose of 10 mg/kg. Comparing the related pharmacokinetic parameters of celecoxib and its metabolites, celecoxib was quickly metabolized into celecoxib-OH and subsequently converted to celecoxib-COOH in short intervals. The AUCs for the two metabolites were less than 10% of that for celecoxib, indicating that the rate of celecoxib metabolism was low. (C) 2014 Elsevier B.V. All rights reserved.
Keywords
HUMAN PLASMA; CLINICAL PHARMACOKINETICS; COLORECTAL ADENOMA; COX-2 INHIBITORS; PREVENTION; EXCRETION; DISEASE; TISSUE; MS/MS; HUMAN PLASMA; CLINICAL PHARMACOKINETICS; COLORECTAL ADENOMA; COX-2 INHIBITORS; PREVENTION; EXCRETION; DISEASE; TISSUE; MS/MS; Celecoxib; Celecoxib metabolites; Quantitation; Liquid chromatography-tandem mass spectrometry; Alternating polarity switching
ISSN
0731-7085
URI
https://pubs.kist.re.kr/handle/201004/125644
DOI
10.1016/j.jpba.2014.12.004
Appears in Collections:
KIST Article > 2015
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE